Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Gilead Sciences (NQ: GILD)
73.28 USD  +0.02 (+0.03%)
Streaming Delayed Price  /  Updated: 4:38 AM EDT, Jun 3, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 589
Open 73.26
Bid (Size) 73.56 (1)
Ask (Size) 73.75 (1)
Prev. Close 73.26
Today's Range 73.26 - 73.28
52wk Range 60.89 - 85.97
Shares Outstanding 1,300,260,832
Dividend Yield 3.04%
Performance
YTD
+12.34%
+12.34%
1 Month
-8.69%
-8.69%
3 Month
-1.25%
-1.25%
6 Month
+10.91%
+10.91%
1 Year
+14.73%
+14.73%
Top News
More News
Are These The Best Biotech Stocks To Buy Or Avoid This Week?
from Stockmarket.com
Mark Genovese Joins Gilead to Lead Clinical Development of Company’s Inflammation Programs
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Mark Genovese, MD, has been appointed Senior Vice President, Inflammation, with responsibility for overseeing the clinical development of the... Read More
from Business Wire News Releases
More News
Read More
UPDATE 3-India approves Gilead's remdesivir to treat severe COVID-19 cases
category companyNews
from Reuters: Company News
UPDATE 2-India approves Gilead's remdesivir to treat severe COVID-19 cases
category companyNews
from Reuters: Company News
UPDATE 1-S.Korea approves emergency use of Gilead's anti-viral drug to treat COVID-19
category companyNews
from Reuters: Company News
S.Korea approves import of anti-viral drug remdesivir for coronavirus treatment
category companyNews
from Reuters: Company News
Coronavirus update: U.S. case tally tops 1.8 million; study finds face masks, social distancing effective at reducing infections
category W , DKS , LAD , and 14 more.
from MarketWatch
UPDATE 1-India approves emergency use of remdesivir to treat COVID-19 patients
category companyNews
from Reuters: Company News
Gilead's next step on coronavirus: inhaled remdesivir, other easier-to-use versions
category companyNews
from Reuters: Company News
Why Bristol Myers' Success In Ulcerative Colitis Sent Arena Stock Flying
from Investor's Business Daily
India approves emergency use of remdesivir to treat COVID-19 patients
category companyNews
from Reuters: Company News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.